AAAAAA

   
Results: 1-7 |
Results: 7
THE PHYSIOLOGICAL CONSEQUENCES OF MACROPHAGE PACIFICATION DURING SEVERE ACUTE-PANCREATITIS
Authors: YANG J DENHAM W TRACEY KJ WANG HC KRAMER AA SALHAB KF NORMAN J
Citation: J. Yang et al., THE PHYSIOLOGICAL CONSEQUENCES OF MACROPHAGE PACIFICATION DURING SEVERE ACUTE-PANCREATITIS, Shock, 10(3), 1998, pp. 169-175
RESPIRATORY SYNCYTIAL VIRUS IMMUNE GLOBULIN FOR PROPHYLAXIS AGAINST RESPIRATORY SYNCYTIAL VIRUS-DISEASE IN INFANTS AND CHILDREN WITH CONGENITAL HEART-DISEASE
Authors: SIMOES EAF SONDHEIMER HM TOP FH MEISSNER HC WELLIVER RC KRAMER AA GROOTHUIS JR
Citation: Eaf. Simoes et al., RESPIRATORY SYNCYTIAL VIRUS IMMUNE GLOBULIN FOR PROPHYLAXIS AGAINST RESPIRATORY SYNCYTIAL VIRUS-DISEASE IN INFANTS AND CHILDREN WITH CONGENITAL HEART-DISEASE, The Journal of pediatrics, 133(4), 1998, pp. 492-499
RESPIRATORY SYNCYTIAL VIRUS (RSV) IMMUNE GLOBULIN INTRAVENOUS THERAPYFOR RSV LOWER RESPIRATORY-TRACT INFECTION IN INFANTS AND YOUNG-CHILDREN AT HIGH-RISK FOR SEVERE RSV INFECTIONS
Authors: RODRIGUEZ WJ GRUBER WC WELLIVER RC GROOTHUIS JR SIMOES EAF MEISSNER HC HEMMING VG HALL CB LEPOW ML ROSAS AJ ROBERTSEN C KRAMER AA KIM HW ARROBIO J MILBURN C BAKER J SATTERWHITE P STEEL L BENDER P KING S LEVIN M ARONOFF S BAER L SANCHEZ J TOP FH HENSEN SA PETERSON MB
Citation: Wj. Rodriguez et al., RESPIRATORY SYNCYTIAL VIRUS (RSV) IMMUNE GLOBULIN INTRAVENOUS THERAPYFOR RSV LOWER RESPIRATORY-TRACT INFECTION IN INFANTS AND YOUNG-CHILDREN AT HIGH-RISK FOR SEVERE RSV INFECTIONS, Pediatrics, 99(3), 1997, pp. 454-461
PROSPECTIVE DEVELOPMENT OF A CARDIAC SCORING SYSTEM TO PREDICT THE SEVERITY AND OUTCOME OF CONGENITAL HEART-DISEASE (CHD)
Authors: SONDHEIMER HM KRAMER AA CARLIN DA GROOTHUIS JR SIMOES EAF
Citation: Hm. Sondheimer et al., PROSPECTIVE DEVELOPMENT OF A CARDIAC SCORING SYSTEM TO PREDICT THE SEVERITY AND OUTCOME OF CONGENITAL HEART-DISEASE (CHD), Pediatric research, 39(4), 1996, pp. 211-211
SAFETY AND BIOEQUIVALENCY OF 3 FORMULATIONS OF RESPIRATORY SYNCTIAL VIRUS-ENRICHED IMMUNOGLOBULIN
Authors: GROOTHUIS JR SIMOES EAF LEHR MV KRAMER AA HEMMING VG RODRIGUEZ WJ ARROBIO J WELLIVER RC SIBER GR
Citation: Jr. Groothuis et al., SAFETY AND BIOEQUIVALENCY OF 3 FORMULATIONS OF RESPIRATORY SYNCTIAL VIRUS-ENRICHED IMMUNOGLOBULIN, Antimicrobial agents and chemotherapy, 39(3), 1995, pp. 668-671
VIRUS-SPECIFIC ANTIBODY-RESPONSES TO HUMAN CYTOMEGALOVIRUS (HCMV) IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED PERSONS WITH HCMV RETINITIS
Authors: BOPPANA SB POLIS MA KRAMER AA BRITT WJ KOENIG S
Citation: Sb. Boppana et al., VIRUS-SPECIFIC ANTIBODY-RESPONSES TO HUMAN CYTOMEGALOVIRUS (HCMV) IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED PERSONS WITH HCMV RETINITIS, The Journal of infectious diseases, 171(1), 1995, pp. 182-185
CANDIDATE RECOMBINANT VACCINE FOR HUMAN B19-PARVOVIRUS
Authors: BANSAL GP HATFIELD JA DUNN FE KRAMER AA BRADY F RIGGIN CH COLLETT MS YOSHIMOTO K KAJIGAYA S YOUNG NS
Citation: Gp. Bansal et al., CANDIDATE RECOMBINANT VACCINE FOR HUMAN B19-PARVOVIRUS, The Journal of infectious diseases, 167(5), 1993, pp. 1034-1044
Risultati: 1-7 |